Heparin-induced thrombocytopenia: Interest and difficulties to identify the immunologic mechanism;Thrombopénies induites par l'héparine: Intérêt et difficultés de l'identification précise d'un mécanisme immunologique

Bulletin de l'Academie Nationale de Medecine

Volumn 182, Issue 7, 1998, Pages 1517-1536

  Samama, Meyer Michel ^a   Elalamy, Ismaïl ^b   Lecrubier, Chantal ^b   Potevin, Françoise ^b   Horellou, Marie Heélène ^b   Conard, Jacqueline ^b  

^a HÔTEL DIEU   (France)

^b NONE

Author keywords

Heparin; Heparin, low molecular weight; Platelet factor 4; Thrombocytopenia, chemically induced

Indexed keywords

ANTIBODY; CALCIUM; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; ANTIBODIES; BLOOD PLATELETS; CALCIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; THROMBOCYTOPENIA;

EID: 0032259602     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. CHONG B.H. - Heparin induced thrombocytopenia. Br J Haematol, 1995, 89, 431-439.
2. AMIRAL J., BRIDEY F., DREYFUS M., VISSAC A.M., FRESSINAUD E., WOLF M., MEYER D. - Platelet-factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb. Haemost., 1992, 68, 95-96.
3. ASTER R.H. - Heparin induced thrombocytopenia and thrombosis. N Engl J Med, 1995, 332, 1374-1376.
4. LECRUBIER C., LECOMPTE T., POTEVIN F., HORJELLOU M.H., CONARD J., SAMAMA M.M. - Heparin induced thrombocytopenia : methodological and diagnostic problems and therapeutic aspects (a study of 26cases). J Mal Vasc, 1987, 12, 128-132.
5. SHERIDAN D., CARTER C., KJELTON J.G. - A diagnostic for heparin induced thrombocylopenia. Blood, 1986, 67, 27-30.
6. CHONG B.H., BURGESS J., ISMAÏL F. - The clinical usefulness of the platelet aggregation test for the diagnosis of heparin induced thrombocytopenia. Thromb Haemost, 1993, 69, 344-350.
7. STEWART M.W., ETCHES W.S., BOSHKOV L.K., GORDON P.A. - Heparin induced thrombocytopenia : an improved method of detection based on lumi-aggregometry. Br J Haematol, 1995, 91, 173-177.
8. WARKENTIN T.E., HAYWARD C.P.M., BOSHKOV L.K. - Sera from patients with heparin induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity : an explanation for the thrombotic complications of heparin induced thrombocytopenia. Blood, 1994, 84, 3691-3699.
9. AMIRAL J., MARFAING-KOKA A., WOLF M., VISSAC A.M., BOYER-NEUMANN C., PONCZ M., MEYER D. - Presence of autoantibodics to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood, 1996, 88[2], 410-416.
10. ELALAMY I., LECRUBIER C., AMIRAL J., POTEVIN F., MARIE J.P., SAMAMA M.M. - Discrepancies between heparin-platelet -induced antibodies (HPIA) test and platelet aggregation test (PAT) : other target for heparin induced antibodies ? Thromb Haemost, 1997, suppl, 449 (abstract).
11. NEWMAN P.M., SWANSON R.L., CHONG BH. - Heparin-induced thrombocytopenia : IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid. Thromb Haemost, 1998, 80, 292-297.
12. TROSSAERT M., GAILLARD A., COMMIN P.L., VESSAC A.M., AMIRAL J., FRESSINAUD E. - High incidence of anti-heparin-PF4 antibodies after cardiopulmonary bypass. Thromb Haemost, 1998, 101, 653-665.
13. ELALAMY I., POTEVIN F., LECRUBIER C., BARA L., MARIE J.P., SAMAMA M.M. - A fatal low molecular weight heparin associated thrombocytopenia after hip surgery : possible usefulness of PF4-heparin ELISA test. Blood Coag Fibrinolys, 1996, 7, 665-671.
14. MAGNANI H.N. - Heparin-induced thrombocytopenia (HIT) an overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost, 1993, 70, 554-561.
15. GREINACHER A. - Recombinant hirudin in the treatment of patients with heparin associated thrombocytopenia type II : A historically controlled clinical trial. In : Recombinant hirudinclinical experiences in heparin-associated thrombocytopenia type II and cardiovascular disease. A Satellite Symposium of the XVIIth Congress of the European Society of Cardiology. Birmingham. United Kingdom, 26 August 1996. Scientific Communications 1997, 8-10.
16. ELALAMY I., LECRUBIER C., POTEVIN F., ABDELOUAHED M., BARA L., MARIE J.P., SAMAMA M. - Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-associated thrombocytopenia. Thromb Haemost, 1995, 74 [5], 1384-1385.
17. LEWIS B.E., WALENGA J.M., WALLIS D.E. - Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome Sem. Thromb Haemost, 1997, 23 [2], 197-202
18. WARKENTIN T.E., CHONG B.H., GREINACHER A. - Heparin-induced Thrombocytopenia : towards Consensus. Thromb Haemost, 1998, 79, 1-7.